TEZSPIREâ„¢ (TEZEPELUMAB-EKKO) NOW AVAILABLE IN THE UNITED STATES FOR THE TREATMENT OF SEVERE ASTHMA
THOUSAND OAKS, Calif., Jan. 13, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced TEZSPIREâ„¢ (tezepelumab-ekko) is now available for shipment to wholesalers in the U.S. TEZSPIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results